Bioanalytical Systems (BASI) Upgraded to C by TheStreet

TheStreet upgraded shares of Bioanalytical Systems (NASDAQ:BASI) from a d+ rating to a c rating in a research note released on Wednesday morning.

Shares of Bioanalytical Systems traded down $0.02, hitting $1.64, on Wednesday, MarketBeat reports. 300 shares of the stock traded hands, compared to its average volume of 28,018. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.72 and a quick ratio of 0.59. Bioanalytical Systems has a twelve month low of $1.76 and a twelve month high of $1.83.

Bioanalytical Systems (NASDAQ:BASI) last issued its quarterly earnings data on Tuesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $5.94 million for the quarter. Bioanalytical Systems had a net margin of 2.35% and a return on equity of 6.39%.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Renaissance Technologies LLC raised its holdings in Bioanalytical Systems by 80.6% in the 4th quarter. Renaissance Technologies LLC now owns 244,200 shares of the company’s stock valued at $598,000 after buying an additional 109,000 shares during the period. Deutsche Bank AG raised its holdings in Bioanalytical Systems by 194.1% in the 4th quarter. Deutsche Bank AG now owns 59,400 shares of the company’s stock valued at $145,000 after buying an additional 39,200 shares during the period. Finally, Acadian Asset Management LLC raised its holdings in Bioanalytical Systems by 240.2% in the 4th quarter. Acadian Asset Management LLC now owns 45,375 shares of the company’s stock valued at $111,000 after buying an additional 32,039 shares during the period. Hedge funds and other institutional investors own 11.05% of the company’s stock.

Bioanalytical Systems Company Profile

Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments.

Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply